Cardiovascular Clinical Studies

This channel includes news and new technology innovations from cardiovascular clinical trials. These clinical studies include all cardiac subspecialties.

Primary endpoints across three studies underscore the importance of accuracy, utility, and efficiency in coronary artery disease diagnostics and clinical decision making
News | Cardiovascular Clinical Studies
HeartFlow to Announce New Data at SCCT23

July 28, 2023 — Respective results from the REVEALPLAQUE, DECODE, and SMART-CT clinical studies demonstrate the accuracy ...

Home July 28, 2023
Home
A multi-institutional team of scientists led by Dr. Mario Gaudino, the Stephen and Suzanne Weiss Professor in Cardiothoracic Surgery and assistant dean for clinical trials at Weill Cornell Medicine, has been approved for a nearly $30 million funding award from the Patient-Centered Outcomes Research Institute (PCORI).
News | Cardiovascular Clinical Studies
Large PCORI Award Funds Study of Surgical Options for Coronary Artery Disease in Underrepresented Patient Populations

July 25, 2023 — A multi-institutional team of scientists led by Dr. Mario Gaudino, the Stephen and Suzanne Weiss ...

Home July 25, 2023
Home
BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary disease, announced that the independent Data Safety Monitoring Board (DSMB) has completed its prespecified data review for the ongoing Phase III pivotal CardiAMP Cell Therapy Heart Failure Trial
News | Cardiovascular Clinical Studies
BioCardia Announces DSMB Recommendation to Pause New Enrollment in Phase III Pivotal CardiAMP Cell Therapy Heart Failure Trial While Additional Blinded Data is Collected

July 24, 2023 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of ...

Home July 24, 2023
Home
SmartfIRE study is evaluating THERMOCOOL SMARTTOUCH SF Dual Energy Catheter’s potential to enable safe and simple procedures with the ability to deliver both radiofrequency (RF) and pulsed field ablation (PFA)
News | Atrial Fibrillation
Biosense Webster Completes Enrollment in Pivotal Trial Evaluating PFA and RF Dual Energy Catheter for Patients with Atrial Fibrillation in Europe

July 21, 2023 — Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson ...

Home July 21, 2023
Home
Pilot study will assess positive impacts of real-time safety monitoring on patient outcomes and treatment experience
News | Remote Monitoring
AliveCor and Thomas Jefferson University Hospital Partner to Evaluate KardiaMobile 6L for QT Prolongation Screening in Patients Treated for Opioid Use Disorder

July 21, 2023 — AliveCor, a leading innovator in FDA-cleared personal electrocardiogram (ECG) technology, today ...

Home July 21, 2023
Home
BicĂŞtre Hospital in Paris, France, and Baptist Stroke & Cerebrovascular Center in Jacksonville, Florida, USA, join global network of leading stroke centers as part of WE-TRUST multicenter clinical trial to evaluate the potential benefits of a Direct to Angio Suite treatment pathway for stroke patients
News | Stroke
First Patients in France and the USA Enrolled in Global WE-TRUST Trial to Accelerate Stroke Diagnosis and Treatment

July 20, 2023 — The first patients in France and the USA have been enrolled into the large-scale WE-TRUST* multicenter ...

Home July 20, 2023
Home
The proposed approach outperforms other neural network architectures by leveraging rich geometric information to segment brain stroke lesion images
News | Stroke
New Geometric Deep Learning Model for Detecting Stroke Lesions

July 19, 2023 — Ischemic stroke, which occurs when a blood vessel in the brain gets blocked by a clot, is among the ...

Home July 19, 2023
Home
A new clinical study in Europe examines the applicability and effectiveness of the new TIMELY Platform for telemedical secondary prevention
News | Artificial Intelligence
AI-Supported Telemedicine Platform Aims to Improve the Health of Patients After Myocardial Infarction and Prevent Reinfarctions

July 18, 2023 — The TIMELY consortium announced today the enrollment of the first patient in the randomized controlled ...

Home July 18, 2023
Home
No statistical difference observed across sub-analyses for diabetes, lesion length, calcium, bailout stenting and occlusions in head-to-head study comparing Passeo-18 Lux DCB to In.Pact Admiral DCB
News | Drug-Eluting Balloons
BIOPACT RCT Subgroup Analyses Show Consistently Great Results for Passeo-18 Lux Drug-Coated Balloon

July 14, 2023 — BIOTRONIK announced the one-year subgroup results from the investigator-initiated BIOPACT randomized ...

Home July 14, 2023
Home
Illustration for the deployment and shaping process of the occluder.
News | Structural Heart Occluders
Transcatheter Closure of Perimembranous Ventricular Septal Defect Using a Novel Fully Bioabsorbable Occluder: Multicenter Randomized Controlled Trial

July 14, 2023 — In recent years, transcatheter intervention techniques have emerged as a promising alternative for the ...

Home July 14, 2023
Home
A subgroup analysis of the HOST-IDEA randomized controlled trial showed efficacy differences of Ultrathin Strut DES
News | Stents Drug Eluting
Late-Breaking Study Data: BIOTRONIK’s Orsiro DES Outperforms Other Ultrathin Strut Drug-Eluting Stent

July 12, 2023 — In a late breaking trial session during EuroPCR 2023 in Paris, on behalf of the HOST-IDEA study ...

Home July 12, 2023
Home
US study seeking to confirm strong efficacy data reported in RED DESERT and SAHARA
News | Heart Failure
Sequana Medical Announces First Patient Enrolled in MOJAVE

July 10, 2023 — Sequana Medical NV, a pioneer in the treatment of fluid overload in liver disease, heart failure and ...

Home July 10, 2023
Home
Coronary computed tomography angiography is a cheaper, less-invasive alternative to intravascular ultrasound in pharmaceutical clinical trials
Feature | Cardiac Imaging | By Matthew Jay Budoff, MD, FACC, FAHA
The Benefits of Coronary CTA in Pharmaceutical Clinical Trials

Coronary computed tomography angiography (CCTA) is cheaper, easier to use and its results are easier to understand than ...

Home July 10, 2023
Home
Atrial fibrillation (AFib) is the most common type of heart arrhythmia. This serious condition occurs when the heart beats so fast that the upper chambers of the heart quiver. This irregular heartbeat can lead to severe conditions, including heart failure, dementia and a fivefold increase in the risk of stroke
News | Atrial Fibrillation
Reduced Levels of FKBP5 Promote Atrial Fibrillation

July 7, 2023 — Atrial fibrillation (AFib) is the most common type of heart arrhythmia. This serious condition occurs ...

Home July 07, 2023
Home
UM School of Medicine faculty develop tool to assess risks earlier in vulnerable patients
News | Cardiovascular Clinical Studies
New Study Highlights Dangers of Cumulative Exposure to Cardiovascular Risks and Need for Earlier Primary Prevention Strategies

July 5, 2023 — With heart disease the most common cause of death worldwide, researchers have attempted to quantify how ...

Home July 05, 2023
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now